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 1 
ABSTRACT 1 
Empirical analysis of the connections between research and health policymaking is scarce in middle-2 
income countries. In this study, we focused on a national multidrug-resistant tuberculosis (MDR-TB) 3 
healthcare provider training program in China as a case study to examine the role that research 4 
plays in influencing health policy. We specifically focused on the factors that influence research 5 
uptake within the complex Chinese policy making process. Qualitative data were collected from 34 6 
participants working at multilateral organizations, funding agencies, academia, government agencies 7 
and hospitals through 14 in-depth interviews and two focus group discussions with ten participants 8 
each. Themes were derived inductively from data and grouped based on the “RAPID” framework 9 
developed by the Overseas Development Institute. We further classified how actors derive their 10 
power to influence policy decisions following the six sources of power identified by Sriram et al. We 11 
found that research uptake by policymakers in China is influenced by perceived importance of the 12 
health issues addressed in the research, relevance of the research to policymakers’ information 13 
needs and government’s priorities, the research quality, and the composition of the research team. 14 
Our analysis identified that international donors are influential in the tuberculosis (TB) policy process 15 
through their financial power. Furthermore, the dual roles of two government agencies as both 16 
evidence providers and actors who have the power to influence policy decisions through their 17 
technical expertise make them natural intermediaries in the TB policy process. We concluded that 18 
resolving the conflict of interests between researchers and policymakers, as suggested in the “two-19 
communities theory”, is not enough to improve evidence use by policymakers. Strategies such as 20 
framing research to accommodate the fast-changing policy environment and making alliances with 21 
key policy actors can be effective to improve communication of research findings into the policy 22 






Recognizing the important role of research in setting priorities and informing resource allocation 28 
decisions particularly in resource-constraint settings (Cordero et al., 2008; Syed et al., 2008), donors 29 
and researchers have increasingly called for using research evidence to inform health policy 30 
decisions (Uneke et al., 2015). However, a literature review identified that the level of using research 31 
to inform health policies in low and middle-income countries (LMICs) is not optimal and that existing 32 
evidence does not always provide information that is critical or  accessible to policymakers (Hawkins 33 
& Parkhursk, 2016; Weiss, 1979). Common barriers influencing research uptake within the 34 
policymaking process still exist, including lack of timeliness in presenting study results, few 35 
communication channels, different conceptions of risk, and mutual mistrust between policymakers 36 
and researchers (Innvaer, Vist, Trommald, & Oxman, 2002; Lavis et al., 2005). Most empirical 37 
analysis of the connections between the use of research evidence and the adoption of policies has 38 
been conducted in high or low-income countries (Burris, Parkhurst, Adu-Sarkodie, & Mayaud, 2011; 39 
Hutchinson et al., 2011; Tulloch et al., 2011). In middle-income countries, studies examining the 40 
public policy process showed how international donors and think tanks influenced the policymaking 41 
process (Fischer & Plehwe, 2017; Handlin, 2015; Pérez-Escamilla et al.; Tran et al., 2017).  42 
 43 
Both international and domestic researchers have attempted to illustrate the health policymaking 44 
process in China by documenting and accounting the context and the process of how new policies 45 
are formulated and translated into practice (He, 2018; Kornreich, Vertinsky, & Potter, 2012; Korolev, 46 
2014; Y. Liu & Rao, 2006; Tang, Brixi, & Bekedam, 2014). As described in one study, the national 47 
policymaking process in China follows three steps (Y. Liu & Rao, 2006). First, the State Council 48 
commissions relevant ministries to draft policy documents in line with the national priorities. A 49 
national agency usually serves as the coordinator (Y. Liu & Rao, 2006). Second, several rounds of 50 
meetings for discussing the details of the policy drafts are held before the policies are finalized (Y. 51 
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Liu & Rao, 2006). Third, once an agreement is achieved, the new policies are announced through 52 
public conferences. (Y. Liu & Rao, 2006) In the health policymaking process, we have seen that 53 
research conducted by universities, national agencies or think tanks played critical roles in shaping 54 
the national priorities and influencing the formulation of policy drafts (He, 2018; Kornreich et al., 55 
2012; Tang et al., 2014). By adopting this evidence-based approach, the policymakers in China have 56 
strengthened the health system by addressing some of the pressing issues, such as using an 57 
innovative financing scheme to provide health insurance for rural population and developing a 58 
national system to supply affordable essential medicines (Y. Liu & Rao, 2006; Tang et al., 2014). 59 
Additionally, researchers shared the lessons drawn from their successful experiences of translating 60 
research into policy and practice, such as undertaking policy relevant studies and conducting timely 61 
research dissemination (He, 2018; Y. Liu & Rao, 2006; Tang et al., 2014).   62 
 63 
However, only limited studies examined the research-policy links from the perspectives of the users 64 
- policymakers. To our knowledge, only two qualitative studies focusing on investigating 65 
policymakers’ opinions on the facilitators and barriers that influence research uptake in the 66 
policymaking process have been conducted  in China (D. Liu, Yuan, Wang, Liu, & Zhou, 2007; Wang, 67 
He, Zhu, & Zhu, 2011). We found that in these two studies, policymakers, who are mostly 68 
administrative officials working in the provincial and local bureaucratic system, are too narrowly 69 
defined. As there is a growing body of literature unveiling the black box of China’s policymaking 70 
process, it is widely accepted that policymaking in China is shifting from a centralized policymaking 71 
process dominated by political and administrative elites to a more open and pluralistic model 72 
influenced by a variety of actors, such as experts, the media, and international organizations (Ma & 73 
Lin, 2012).  74 
 75 
In this study, we focused on a national multidrug-resistant tuberculosis (MDR-TB) healthcare 76 
provider (HCP) training program in China as a case study to explore the factors that influence 77 
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research uptake in the policy setting using a widely-accepted analysis framework. Furthermore, from 78 
shared experiences and lessons provided by Chinese policy actors, we developed practical strategies 79 
to facilitate and strengthen research uptake in the health policymaking process. 80 
 81 
To understand the role that research plays in influencing policy, researchers have proposed various 82 
frameworks and models. For example, Weiss in 1979 postulated six models of research utilization 83 
(Weiss, 1979). In that same year, Caplan proposed the two-communities theory to elucidate the 84 
fundamental reasons for the lack of research use in the policy process (Caplan, 1979). The two-85 
communities theory emphasizes the idea that being two separate communities, researchers and 86 
policymakers operate in different cultures; have conflicting values; engage in different activities; 87 
have different attitudes to research; and they have different priorities and accountability 88 
mechanisms (Caplan, 1979). 89 
 90 
More recent studies have suggested that previous theories often overlooked the complex 91 
environment where research is conducted and how policy decisions are made (Bowen & Zwi, 2005; 92 
de Goede, Putters, & van Oers, 2012). As emphasized by Bowen and Zwi, because policymaking 93 
context is usually fast-changing, considering how research evidence fits into context is critical to 94 
understand its uptake (Bowen & Zwi, 2005). Additionally, several studies supported the idea that 95 
knowledge generated from research is highly context sensitive, and that the application of this 96 
knowledge in another context can change its value (Bal, Bijker, & Hendriks, 2004; Lin & Gibson, 97 
2003). Furthermore, since 2000, researchers have called for a social network approach to studying 98 
research use in the policymaking process since the boundaries of researchers and policy makers are 99 
considered fluid and have become more blurred in recent years (Davies, Nutley, & Smith, 2000; 100 






To achieve our study objectives, we used the Chinese TB policymakers’ perception of the usefulness 106 
of evidence from training evaluations for making resource allocation decisions as a case study to 107 
identify factors that influence research uptake in the health policymaking process in China. 108 
Therefore, we adopted the instrumental case study approach, which seeks to gain a broader 109 
understanding of a phenomenon through a particular case and generates findings transferrable to 110 
other contexts (Stake, 1995).  111 
 112 
The case study setting: making investment decisions on a national HCP training program in China 113 
China ranks the second highest country with MDR-TB - caused by bacteria resistant to two of the 114 
most powerful anti-tuberculosis (TB) drugs, isoniazid and rifampicin – with an estimated of 73,000 115 
incident cases in 2016 (WHO, 2017). Lack of skilled HCPs in peripheral areas and inadequate service 116 
quality are the major challenges for China to reduce both TB and MDR-TB epidemics (Comolet, 117 
Rakotomalala, & Rajaonarioa, 1998; Johansson & Winkvist, 2002). The centralization of MDR-TB 118 
services causes both physical and financial barriers for rural patients to access MDR-TB care (Li et al., 119 
2012; Long, Smith, Zhang, Tang, & Garner, 2011). Therefore, innovate service delivery models that 120 
aim to decentralize TB/MDR-TB services have been designed and piloted in several provinces since 121 
the 2000s (Zou, Wei, Walley, Yin, & Sun, 2012).  122 
 123 
Since China adopted the DOTS strategy in the 1990s, the China CDC has collaborated with 124 
international funders and NGOs closely. As a result of the increasing domestic funding for TB over 125 
the years, TB diagnosis (including X-ray examination and sputum smear tests) and the first-line TB 126 
drugs are provided free of charge at the TB dispensaries and designated hospitals under the national 127 
TB control and prevention strategy. However, there is no designated funding for MDR-TB diagnosis 128 
and treatment from the national government. This gap was filled by several interventional programs 129 
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funded by international donors, such as the Bill and Melinda Gates Foundation and the Global Fund 130 
to Fight AIDS, TB and malaria, since 2006. Today there remains a shortfall of funding to sustain MDR-131 
TB control activities and MDR-TB control is still relying on funding from international donors. 132 
 133 
In 2015, the National Center for TB control of the Chinese Center for Disease Control and Prevention 134 
(NCTB), the national Clinical Center for TB control of the China CDC (CCTB), and the Lilly MDR-TB 135 
Partnership collaboratively initiated a training program targeting TB HCP particularly in peripheral 136 
healthcare centers and hospitals. The aim of the program was to standardize MDR-TB diagnosis and 137 
improve case management by HCPs in China. This national training program was critical to the 138 
successful reform of the service delivery system because a shortage of well-trained HCPs at lower 139 
level facilities might hinder the possibility of decentralizing MDR-TB services. To inform decisions on 140 
nationwide implementation of the training program, pilot sites were established in six provinces 141 
across China. In each province, clinical doctors, nurses, and local CDC staff who were involved in 142 
delivering care to MDR-TB patients in local CDCs and TB designated hospitals were included in the 143 
training program. As the program and the funding from the donor ended in 2017, a decision needs 144 
to be made by the policymakers in China whether the program could be sustained and even scaled 145 
up to other provinces using internal funding from the National Health and Family Planning 146 
Commission (NHFPC). To provide evidence for the policymakers to make this decision, a policy-147 
relevant evaluation of the pilot training program was needed.  148 
 149 
Data collection 150 
Data was collected from three main sources: semi-structured interviews, focus group discussions 151 
with key policy actors, and a review of government documents. In this study, we define policy actors 152 
broadly as decision-makers who directly authorize and inform health policy or program formulation, 153 
resource allocation and individuals or groups who have knowledge, indirect influence or are affected 154 
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by policymaking making processes (Khan, Meghani, Liverani, Roychowdhury, & Parkhurst, 2018; 155 
Shannon, 2003).  156 
 157 
In 2016 and 2017, we conducted a qualitative study with policy actors of the MDR-TB HCP training 158 
program. We also included some interviewees who are external to the program but could provide 159 
information on the contextual factors that shape the policy process.  A purposive sampling approach 160 
was used to identify key policy actors. A total of 34 participants were recruited and participated in 161 
the study, including international actors based in multilateral organizations, funding agencies, and 162 
the academic sector and national actors, such as directors of provincial and national CDCs in China, 163 
high-level representatives of the CCTB, and senior staff at tertiary hospitals leading HCP training 164 
programs. A detailed description of study participants is shown in Table 1. Participants were 165 
contacted and recruited through conference calls and email. Oral consent to participate in the study 166 
was obtained prior to the study. We conducted fourteen face-to-face semi-structured in-depth 167 
interviews (IDIs) and two focus group discussions (FGDs) with ten participants each. Topics covered 168 
in the IDIs and FGDs included: contextual factors affecting the policy process, limitations of current 169 
training evaluation approaches, information needed to determine if a training program is successful, 170 
factors policy actors consider important when presented with an evaluation report, how 171 
policymakers and researchers interact, and how policy actors weigh different sources of information. 172 
The majority of interviews were conducted in Chinese by SW, and four interviews were conducted 173 
by HL-Q in English. All interviews were audio-recorded and transcribed into Chinese and English.  174 
 175 
In addition to the interviews and FGDs, we reviewed documents from government websites 176 
pertaining to the national MDR-TB HCP training program, roles and responsibilities of the involved 177 
agencies as a way of triangulation for and complementary to the data from IDIs and FGDs. 178 
 179 
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The research was approved by the Institutional Review Board of the National University of Singapore 180 
and the London School of Hygiene and Tropical Medicine. Information sheets that summarized the 181 
objectives and methods of the research and consent forms were provided to the participants. 182 
Participants were informed of the confidentiality and anonymity of their responses. To ensure 183 
confidentiality, participants were de-identified and numbered during transcription. 184 
 185 
Conceptual framework  186 
During data analysis, we reviewed frameworks from literature and searched for the appropriate one 187 
that we could use to group the emerging codes and subthemes emerged. We first identified 188 
frameworks that focus on the on the dynamic relationships between actors involved in research use 189 
and the policy formulation process. For example, the research utilization framework proposed by 190 
Kim et al. is a four-phase model that illustrates the process of translating research evidence into 191 
policies and practices (Kim et al., 2018). Different from other more theoretical models, this 192 
framework is particularly useful in real-world settings with its emphasis on evidence use throughout 193 
program cycles. Another notable framework is the knowledge translation model developed from a 194 
systematic literature review by Orem et al., which identified eight groups of factors facilitating 195 
research evidence use in the policy process, such as strengthening institutional capacity for 196 
knowledge translation, setting priorities at pre-research stage, political and economic context (Orem 197 
et al., 2012). Employing a qualitative approach to engage inputs from policymakers in Uganda, the 198 
authors further refined this framework to fit low-income settings, where external donors had strong 199 
influences on the health policy development and implementation.  200 
 201 
Compared to the above-mentioned models and frameworks for explaining and facilitating research 202 
use in the policy process, the four-dimensional model developed by the Overseas Development 203 
Institute (ODI) resonated with our data. The Research and Policy in Developing countries (RAPID) 204 
framework emphasizes the relationship and communication channels between researchers and 205 
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policy actors as key components, as well as the nature of the evidence and the contextual factors 206 
influencing such interactions (Crewe & Young, 2002). It was based on 50 case studies examining how 207 
research evidence was taken up and influenced policy decisions (Burris et al., 2011), and widely 208 
applied in the empirical analysis of the research-policy links in LMICs (Crichton & Theobald, 2011; 209 
Hutchinson et al., 2011; Tulloch et al., 2011). With its simplicity and validated applicability in low- 210 
and middle-income settings, the framework provides a general scaffold for researchers to develop a 211 
wide range of pathways of research adoption in different policy contexts and facilitates the 212 
comparison of studies conducted in different countries.  213 
 214 
The RAPID framework highlights that the factors that influence research uptake by policy actors can 215 
be summarized in four dimensions: external environment, political context, evidence, and links 216 
(Start & Holvland, 2004).  External environment describes the global socio-economic trends, or the 217 
influence exerted by international actors on the policy process (Start & Holvland, 2004). Political 218 
context refers to the environment under which research and policymaking are shaped (Court, 2006; 219 
Crewe & Young, 2002). Examples of policy context include organizational pressures, social and 220 
cultural context, and whether a policy is implemented thoroughly in practice (Crichton & Theobald, 221 
2011). The nature of evidence, such as credibility and the way it is communicated to policy actors, 222 
also determines the usefulness of the research findings. Finally, the “links” in the RAPID framework 223 
refers to the relationship and communication channels between researchers and policymakers 224 
which are also critical components of the research-policy interface (Crewe & Young, 2002). To 225 
understand “links”, researchers need to examine, for example, who are the actors making policy 226 
decisions; what power do they have to influence policies; and if there are intermediaries or 227 
“knowledge brokers” between decision-makers and evidence providers (Start & Holvland, 2004). In 228 
this context, policy networks are sets of relatively stable relationships formed by actors who share 229 
common interests or exchange resources to achieve a common policy outcome (Börzel, 1997). Based 230 
on our understanding of the policy actors’ responsibilities in the training program and the TB control 231 
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system, we further classify how actors derive their power to influence policy decisions following the 232 
six sources of power identified by Sriram et al (2018). These include technical expertise, bureaucratic 233 
power, political power, financial power, network and access, and personal attributes (Sriram et al., 234 
2018).  235 
 236 
Analysis 237 
All interviews and FGDs were conducted in Chinese by the first author, and transcripts were 238 
translated into English by the first author (a native Chinese speaker). To reduce error in translation, 239 
the first author consulted another Chinese native speaker on terms and sentences that the first 240 
author was not sure how to translate. Data from documentation was also translated into English and 241 
used to supplement the data from interviews and FGDs. 242 
 243 
Data from IDIs and FGDs was analyzed using a mix of inductive and deductive approaches. 244 
Translated transcripts were imported into NVIVO 11 Software and coded inductively line by line by 245 
two researchers independently. Codes were compared and further merged into subthemes using an 246 
iterative process. The subthemes which were identified inductively were further grouped into the 247 
four themes of the RAPID framework. Policy actors’ roles and their sources of power in making 248 
decisions on TB programs and policies were synthesized based on information from all data sources. 249 
For IDIs, each excerpt includes the interviewee’s ID number and his/her occupation so that extracts 250 
from the same individual can be linked. For FGDs, quotes are identified by the focus group number 251 
and participants’ ID number. In this study, saturation was defined according to the concept of the 252 
priori theoretical saturation that pre-determined theoretical categories are adequately represented 253 
and exemplified by lower-level codes and themes derived from the data (Saunders et al., 2018). We 254 
believe the four constructs of the RAPID framework were adequately represented by our data 255 




The findings are presented according to the four themes of the RAPID framework in the following 259 
order: external environment, political context, evidence and links. We inductively identified several 260 
subthemes for each main theme. In the first theme, external environment, we describe the influence 261 
of international donors on priority setting. Subthemes related to political context included the 262 
government prioritization of health issues and the governments’ perception of the urgency to 263 
address the health issue. Relevance to policy actors’ information needs, credibility perceived by 264 
policy actors, and the composition of research team were identified as key evidence subthemes. 265 
Finally, subthemes related to links involved the distinct roles and responsibilities of policy actors and 266 
the links, power relations, and networks of the policy actors involved in the training program.  267 
 268 
External environment 269 
Influence of international donors on priority setting 270 
The priorities in the TB prevention strategy were determined by the national government, but 271 
influenced by international donors. One international policy actor mentioned that funding from 272 
international donors for communicable diseases is decreasing in Asia and that it is common that 273 
countries with rapid economic growth will eventually lose funding from donors. However, most of 274 
the international policymakers acknowledged that China still receives a large amount of funding 275 
from international organizations despite its rapid economic growth. One of the reasons for this, as 276 
one participant surmised, could be that it would be easier to implement pilot programs or 277 
experimental reforms using foreign loans or funding than using domestic resources. Another reason, 278 
as pointed out by one Chinese policy actor, was that due to the heavy TB burden in China, 279 
particularly with the emergence of more complicated subtypes of TB, resources solely from the 280 
national government could hardly sustain comprehensive control programs to tackle the health 281 
issues at national scale.  282 
 283 
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Therefore, financial support from international donors was still considered relevant in determining 284 
the types and scale of health programs to be implemented in China, through which donors directly 285 
influenced the issues to be prioritized. The policy actors we interviewed acknowledged that since the 286 
1990s, the NCTB started partnership with donors such as the World Bank, the Global Fund and the 287 
Bill and Melinda Gates Foundation, who provided both financial and technical support in TB control 288 
at national scale. For example, the World Bank project built infrastructure for TB prevention and 289 
control covering county-level CDCs, community and village health centers, provided free diagnosis 290 
and drugs for TB patients, and offered stipend for transportation to TB designated health centers 291 
(Kong, Zhang, Wang, & Jiang, 2011). The project was highly praised by the Chinese government 292 
because it facilitated improvement of DOTS coverage, case detection, and established a country-293 
specific model of case management that was later deployed nationwide (Finance Department of 294 
Henan Province; Kong et al., 2011). Apart from their direct influence through funding disease-295 
specific programs, international donors often indirectly shaped the evidence base to inform future 296 
policies or agenda setting through producing evidence from their funded programs. For example, 297 
one policy actor commented that if evidence showed that the programs funded by the donors were 298 
effective, the national government would be more willing to invest in similar programs: 299 
“The NHFPC and Ministry of Finance (MOF) saw the effectiveness of investment, then they 300 
decided to allocate more funds for TB control. And the funding has increased gradually each 301 
year. […] Because of the impact of the international programs, the Chinese government was 302 
able to understand that you have to invest money so that the work can be done. And it 303 
further promoted the implementation of TB interventions and programs.” – IDI 2, CCTB 304 
official  305 
 306 
However, as commented by a few international policy actors, the influence of international donors 307 
was much less in China than in other developing countries, because donors were working in a 308 
unified way, thus exerting more leverage with local governments, in low-income countries.  309 
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“In very low-income countries, you find the donors work together because they have the 310 
opportunity to really have an impact on the government. If they line up together, they can 311 
have a huge impact on the government. In China, there’s no donor coordination. It’s really 312 
falling off because they’re becoming richer and they’re starting to play off the donors.” – IDI 313 
14, Academia 314 
International donors are strongly influential in setting priorities in TB control in China through either 315 
funding the health interventions of their interest or shaping evidence base to inform future policies.  316 
 317 
Political context 318 
Alignment with government priority 319 
Several policy actors described the important role of political context in shaping their attitudes 320 
towards research evidence. They emphasized that the relevance of the research presented - in our 321 
case study, results from evaluation studies - depended on whether the health intervention was in 322 
line with government’s priorities. According to a description given by one interviewee, a 323 
commitment to tackle TB and reach 90% DOTS coverage was made by the Minister of Health at the 324 
Ministerial Conference on Tuberculosis and Sustainable Development in 2000. Because of increased 325 
political commitment, TB control became a priority and was included in the national five-year and 326 
ten-year plan issued by the state council of China since then. As a consequence, the funding for TB 327 
control from the national government increased each year. In 2011, the state council announced the 328 
“five-year plan for the national TB prevention and control”, in which the government highlighted 329 
work priorities for TB control and announced targets to be reached at the end of 2015. Most policy 330 
actors from the NCTB and CCTB confirmed that strengthening human capacity for TB control was 331 
one of the government’s interests and priorities in the “five-year plan” (State Council of China, 332 
2011). As a result, HCP training programs were conducted throughout the years, although the 333 
coverage of the programs varied depending on the availability of the funding allocated annually. The 334 
 14 
next quote highlights how training programs remain a priority as it is part of a broader policy 335 
supported by the government:  336 
“One of the key programs is the training program. […] So no matter how much you are 337 
funded, the training will be part of the overall TB control intervention, but its proportion will 338 
not change much. If the scale of the TB control intervention is increased with more funding, 339 
the investment in training will not change much.” – IDI 2, CCTB official 340 
 341 
Importance and urgency on the need to address the health issue   342 
The value of research perceived by policy actors is influenced by the urgency of the health issues 343 
that the research aims to address. All policy actors we interviewed acknowledged that training HCPs 344 
was a critical factor for ultimately reducing MDR-TB epidemics in China. They emphasized that 345 
doctors from peripheral health facilities, particularly in less developed regions in China, were in need 346 
of systematic training to provide quality MDR-TB services, which would also facilitate achieving the 347 
TB prevention targets at the endpoint of the “five-year plan”. Therefore, the policy actors were 348 
interested to know whether the program effectively improved trainees’ knowledge and skills on 349 
MDR-TB diagnosis and treatment. The next quote summarizes the sentiment of several interviewees 350 
where they regarded training as a key priority due to the need to standardize MDR-TB diagnosis, 351 
treatment and management: 352 
“Especially, HCPs need training for standardized MDR-TB diagnosis, treatment and 353 
management. The HCPs in eastern provinces, which are highly developed, can learn and 354 
apply the latest knowledge and techniques quickly. But in the western provinces, if you don’t 355 
invest resources and funding for them to conduct training, they don’t even have the facilities 356 
or equipment..”—IDI 10, NCTB official 357 
 358 
With only limited resources available, TB interventions often face competition with interventions for 359 
other infectious diseases, such as HIV and Hepatitis B, for government funding. To ensure solutions 360 
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are proposed and resources are allocated to address the TB epidemics in China, political 361 
commitment by the national government is critical. Without political commitment to tackle health 362 
issues, policymakers will have little interest in investing resources or obtaining research evidence to 363 
inform policy. 364 
 365 
Evidence 366 
Relevance to policy actors’ information needs 367 
One of the major determinants of the usefulness of research evidence was whether research 368 
findings addressed policy actors’ information needs. For example, when evaluating a training 369 
program, most policy actors we interviewed found that the assessment of the four basic outcome 370 
levels suggested in the Kirkpatrick Model did not provide enough information that they were 371 
interested. As a classic framework for training evaluation, the Kirkpatrick model defines that the 372 
effectiveness of a training program can be assessed by four indicators: trainees’ affective reaction to 373 
the program, their knowledge improvement, on-the-job behavior change after training, and the 374 
organizational impact of the training program (Kirkpatrick, 2006). Thus, evaluation based solely on 375 
this framework was perceived less useful when determining the future of the training program. Even 376 
though no consensus on the optimal indicators and approach to evaluate effectiveness, most policy 377 
actors in both FGDs agreed that they were interested in information that would help them 378 
determine the sustainability and scalability of the training program, including the cost-effectiveness 379 
of running the training program, the willingness of international donors to invest in the program in 380 
long-term, and whether the program could be easily applicable to other settings. The next quotes 381 
highlight the several areas that interviewees mention as being crucial for policymakers:  382 
“In order to persuade the government to invest, we probably do a cost-effectiveness analysis 383 
to show how much we invest and input, which would impress the policymakers.” – FGD 384 
group A, ID4 385 
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“We need to know if the program is applicable to other settings. If this program targets the 386 
issues in only one or two provinces, then it is not worth scaling-up.” – FGD group B, ID4 387 
 388 
Credibility perceived by policy actors 389 
In addition to the relevance of the research to policy actors, we also found that the scientific quality 390 
of research would influence its perceived credibility and thus determine whether the results would 391 
be useful in the policymaking process. In our scenario, most policy actors were concerned with the 392 
design and validity of the evaluation approach, including whether the indicators used were able to 393 
reflect measured outcomes objectively, whether the methods were validated and whether 394 
confounders were taken into consideration. The next quote illustrates policy actors’ concerns about 395 
the credibility of the research: 396 
We think this outcome indicator [case detection] is important, but we are not sure if this 397 
indicator is able to reflect the results of this training objectively, which is the problem.  – FGD 398 
group B, ID 8 399 
 400 
Composition of research team 401 
Apart from the scientific quality of the research, most policy actors were interested in who 402 
conducted the research. Several policy actors mentioned that although local researchers might be 403 
familiar with the local system, culture and language, they were concerned that the close 404 
relationships between researchers and the local managers of training programs would cause bias in 405 
the assessment. Most policy actors suggested that international researchers were able to conduct 406 
more objective studies compared to local researchers since they held no conflict of interests. In 407 
addition, specific respondents highlighted that the reputation and international impact of 408 
international researchers would raise the credibility of the evaluation results (FGD Group A, ID1 and 409 
ID7). However, some participants were also concerned that international researchers were limited 410 
by their knowledge of local culture and language, which would impede the progress of the 411 
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evaluation. Therefore, as quoted below, a consensus was made across interviews and FGDs that a 412 
mix of international and local researchers in the research team would be ideal.  413 
 “A collaboration will be better, because the methodology used for evaluation by 414 
international researchers would be more robust, even though the process (of evaluation) 415 
might be complex. Researchers in China are more familiar with the local context.” – FGD, 416 
Group B, ID7 417 
 418 
Links, networks, and power relations 419 
Roles and responsibilities of policy actors and their major sources of power 420 
Examining the identities and responsibilities of actors involved in making health policy decisions is 421 
important to understand how policy change occurs and how information is transferred in the 422 
process. In our analysis, we identified key policy actors involved in the HCP training program and 423 
they shared their views on their roles in this training program and TB control system (table 2).  424 
 425 
Policy actors such as international donors, NHFPC, MOF, TB experts, NCTB and CCTB played 426 
important roles in making decisions on the training program and TB policies. Both NCTB and CCTB 427 
are operated under the China CDC system. As the head of the regional CDC network, the NCTB is 428 
responsible for the public health aspects of TB control; while the CCTB, also the headquarter of the 429 
Chinese Medical Association TB division, is responsible for the clinical aspect.  430 
 431 
As described by one Chinese policy actor, it was usually the NHFPC who initiated policymaking and 432 
were responsible for organizing meetings with relevant agencies to discuss policy details and draft 433 
documents. The national TB prevention plans (such as the “five-year plan”), in which work priorities 434 
and targets were established, was drafted and developed by the NHFPC with input from TB experts 435 
in reputable research institutions, NCTB and CCTB. Identified themselves as “consultant of NHFPC”, 436 
participants from both the NCTB and CCTB were involved in conducting TB related research and 437 
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national surveys, and collecting research evidence to justify policy advocacies. As discussed 438 
previously, because of the limited resources and funding provided by the national MOF, the NCTB 439 
and CCTB established collaboration with international donors, who provided additional funding for 440 
TB programs across the country. For these collaborated TB programs (such as the Lilly MDR-TB HCP 441 
training program), the NCTB and CCTB took the leading role in designing and planning the programs. 442 
Additionally, both agencies were responsible for supervising and evaluating the programs during and 443 
at the end of implementation.  444 
 445 
Even though not directly involved in the decision-making process, senior staff at TB designated 446 
hospitals reported that they were able to raise issues encountered during the implementation of TB 447 
programs or policies to TB experts and officials from NCTB or CCTB during workshops or conferences 448 
so that their opinions could pass to higher level decision-makers. However, grassroots doctors who 449 
were responsible for frontline clinical work and research were not reported to be involved in the 450 
decision-making process and had not yet seen any influence over decisions on the HCP training 451 
programs or other TB policies. 452 
 453 
Policy actors’ major sources of power 454 
The power of policy actors derives from difference sources, such as resources, knowledge or 455 
personal attributes (Sriram et al., 2018). We listed the major sources of power for each actor in table 456 
2. As the two major funding sources for TB control activities, international donors and MOF draw 457 
power from their ability to mobilize financial resources. The power of the NHCF on setting national 458 
policy priorities and TB control strategies derives from its authority in the bureaucratic and 459 
administrative system through which health policies are formulated and implemented. With their 460 
ability to produce information and in-depth knowledge and experiences of clinical and epidemic TB 461 
control, the NCTB, CCTB, experts and provincial CDCs exert power on TB programs and policies 462 
through their technical expertise. Additionally, NCTB and CCTB have the bureaucratic power granted 463 
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by their position in the administrative system as they have the authority to design and implement TB 464 
programs and policies. However, the roles of TB designated hospitals and grassroots doctors in the 465 
decision-making process are not comprehensively discussed based on the available data in our 466 
study, thus, their sources of power cannot be clearly accounted for.  467 
 468 
Links between policy actors involved in the training program  469 
The structure of the policy actors involved in the TB policymaking process in China is shown in figure 470 
1. Determined by their positions and power in the health system, the MOF and NHFPC are the top-471 
level policymakers, setting the policy priorities and leading the development of national TB control 472 
strategies. Having both technical and bureaucratic power in the TB control system, the TB experts, 473 
NCTB and CCTB are the high-level policy actors who work closely with the top-level policymakers, as 474 
they play advisory roles to the top-level policymakers and are responsible for drafting policy 475 
documents and national guidelines. The top- and high-level policy actors are directly involved and 476 
most influential in the TB policymaking process.  The lower-level policy actors include provincial 477 
CDCs, TB designated hospitals and TB doctors, as their major roles is providing TB related services 478 
and implementing the policies and programs formulated by the higher-level policy actors. Although 479 
the lower-level policy actors are not always involved in the decision-making process directly, they 480 
can indirectly influence the TB policies through their technical power, thus having relatively less 481 
impact on the policymaking process. As external policy actors, international donors do not directly 482 
participate in the policymaking process in China, but can exert influences through their connections 483 
with the higher-level policy actors and financial power. 484 
 485 
The NCTB and CCTB are in the center of the policy network linking the other actors who are involved 486 
in making decisions on TB programs and policies, as one of the officials from CCTB described their 487 
position in the national TB control system as such: 488 
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“We are working from the upper level. We work with MOH (now known as NHFPC) and also 489 
work with the provincial, prefecture and county level TB hospitals. And of course, we have a 490 
lot of communication with the CDC system.” – IDI 4, CCTB official 491 
Leaders in the two agencies are influential in formulating TB policies and programs through their 492 
roles as advisers to higher level policymakers in the NHFPC. They are  also informed on the progress 493 
of t frontline TB control work and the progress of TB research through their networks with 494 
universities and TB designated hospitals. Furthermore, both agencies had direct contact with 495 
international donors, thus connecting the donors with the NHFPC and MOF.  496 
 497 
DISCUSSION 498 
Our study identified the critical roles of the NCTB and CCTB in making decisions on TB policies and 499 
programs around two key areas. Firstly, as both producers and users of research evidence, the two 500 
agencies have power and influence in the TB policy process through their technical expertise. 501 
Secondly, having connections with other policy actors, the NCTB and CCTB hold a central position of 502 
disseminating information within the TB control system. Additionally, we found that international 503 
donors have a strong influence on setting TB control priorities in China, which in turn will influence 504 
domestic policymakers’ perception of the value of the research because policymakers are interested 505 
in studies that address government priorities. Table 3 summarizes the major findings of our study 506 
according to the four elements of the RAPID framework and we made our recommendations to 507 
improve research use based on these findings.   508 
 509 
The two-communities theory explains why research is not used in the policy process by attributing 510 
non-utilization to the differences in culture between researchers and policymakers (Caplan, 1979). 511 
However, as criticized by Wingens, since the theory focuses on the differences of researchers’ and 512 
policymakers’ practice, it fails to capture the intrinsic differences in functionality of “research” and 513 
“policy” (Wingens, 1990). Thus, even though the theory still holds true to some extent, its 514 
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generalizability is limited. For example, one of the central arguments of the theory is that 515 
researchers and policymakers are two distinct homogenous groups; however, our study suggested 516 
that the identities of “researcher” and “policymaker” are sometimes not mutually exclusive. As 517 
indicated in our study, key member from the NCTB or CCTB are both “researchers” and 518 
“policymakers”: they have the power of making decisions on TB control strategies conferred by their 519 
technical capacity and institutional position in the health system, but are also involved in conducting 520 
research, providing important evidence for making decisions for higher-level policymakers.  521 
 522 
Mirroring the roles of the epistemic community, the two government agencies, the CCTB and NCTB, 523 
have the  expertise and authoritative claim to knowledge about TB prevention and control. They can 524 
influence higher-level policymakers either by directly providing information of policymakers’ needs 525 
or illuminating the importance of an issue from which the policymakers can deduce their interests 526 
and needs. Even though government agencies are important sources of research information (Sorian 527 
& Baugh, 2002), their how to engage them to facilitate research uptake by policymakers are not 528 
sufficiently examined and discussed in current literature. The use of knowledge brokers, who are 529 
usually hired externally by research institutions for facilitating interactions between decision-makers 530 
and researchers, was seen in several developed countries and LMICs (Knight & Lyall, 2013; Mc 531 
Sween-Cadieux, Dagenais, Somé, & Ridde, 2019). Compare to knowledge brokers, staff from the two 532 
agencies have the following advantages as natural intermediaries. Firstly, through years of working 533 
in the TB control system with people from NHFPC, lower level CDCs, hospitals and even international 534 
donors, both agencies already built personal and formal communication channels to circulate 535 
information to colleagues and partners. Secondly, although the use of knowledge brokers was 536 
piloted and proved to be successful in a number of research institutions in UK and Canada (Dagenais, 537 
Laurendeau, & Briand-Lamarche, 2015; Lightowler & Knight, 2013), the sustainability of knowledge 538 
brokers roles is still challenging due to ambiguity in their professional boundaries, career pathways, 539 
recruitment criteria and management (Chew, Armstrong, & Martin, 2013). Therefore, we 540 
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recommend that without the immediate availability of knowledge brokers, partnership can be 541 
established with natural intermediaries, for example, staff from the NCTB or CCTB in our context, to 542 
facilitate the dissemination of research findings. Specifically, as summarized in table 3, researchers 543 
can engage officials from the NCTB or CCTB in designing and conducting research projects. 544 
Interacting and building personal relationships with TB experts or officials from the two agencies are 545 
also helpful to increase the use of research by policy actors.  546 
 547 
 548 
 Our study supports findings from previous studies that the perceived value of research to 549 
policymakers is determined by whether the research addresses a health issue that is in line with 550 
government priorities (Burris et al., 2011; Crichton & Theobald, 2011; Hutchinson et al., 2011). In our 551 
case study, we found that similar to other aid-dependent countries, international donors are 552 
strongly influential in setting priorities and agenda in TB control in China through funding the health 553 
interventions of donors’ interests or shaping evidence base to inform future policies, even though its 554 
perceived influence is less in China and middle-income countries than in low-income countries (Khan 555 
et al., 2018). Today TB (particularly MDR-TB) control in China is still largely relying on funding from 556 
international donors. Since China is gradually acknowledged as one of the emerging economic power 557 
globally and is expected to step up and take the ownership of national disease control by increasing 558 
its spending on TB, how it will influence donors’ resource allocation decisions in China in the future 559 
is still unknown. However, we cannot discard the possibility that if foreign aid declines, policymakers 560 
will likely need to reset the TB control priorities since there will be less influence from international 561 
donors but a large funding gap for disease control activities. If this is the case, the government needs 562 
to make two decisions. For the short-term, if no imminent investment in MDR-TB control from either 563 
the national government or international donors is committed, the policymakers need to carefully 564 
determine what interventions are essential and where to use the very limited available resources to 565 
achieve the optimal outcomes. For the long-term, in line with the ongoing comprehensive health 566 
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system reform that emphasizes the leading role of government in funding and supervision, an 567 
innovative financing mechanism that utilizes domestic sources (for example, health insurance 568 
schemes, central and local public health funding) needs to be established to support sustainable, 569 
affordable and quality MDR-TB services. To accommodate to the fast-changing policy context, we 570 
recommend researchers to conduct a rapid  assessment of the policy context as suggested in table 3. 571 
Furthermore, the private corporate actors are seen to exert influence on the public sector in several 572 
LMICs through corporate policy entrepreneurship, a processes in which “private sector organizations 573 
undertake a set of strategies that result in innovate activities in the public arena”. One example is 574 
the adoption of mobile healthcare payment innovation by the public hospital systems in China. 575 
Therefore, drawing on lessons learned from policy entrepreneurs, health researchers may seek 576 
opportunities for policy influence proactively, instead of waiting passively for their research to be 577 
discovered by policymakers.  578 
 579 
 580 
Consistent with previous studies, our findings indicated that perceived relevance was one factor for 581 
research use in policy decisions and that the scientific quality of research will influence its credibility 582 
perceived by policy actors (Crichton & Theobald, 2011; Innvaer et al., 2002; Lavis et al., 2005). 583 
Contrary to one study which showed that the perceived quality was largely determined by the 584 
reputation of the researchers and the journal where the study was published (Trostle, Bronfman, & 585 
Langer, 1999), our study found that the policy actors in China are more interested in the validity of 586 
the study design and the interpretation of the results. Furthermore, although it is found in previous 587 
studies that research results too complex and technical to be understood by policy actors are 588 
unlikely to be used in policymaking process (Poot et al., 2018; Sorian & Baugh, 2002), the ability of 589 
policy actors to interpret results was not discussed in our study. This is probably because all the 590 
participants in our study have medical backgrounds and are specialized in TB control, they tend to 591 
assess the usefulness of research evidence from a technical perspective. In summary (shown in table 592 
 24 
3), well-designed studies that target policy actors’ information gap are more likely to be used in the 593 
policymaking process. To further increase the perceived credibility, we recommend that study 594 
results need to be critically interpreted and justified.  595 
 596 
Our study has a number of limitations. First, we acknowledge that different systems are deployed 597 
for the management of infectious diseases and non-communicable diseases. Thus, key stakeholders 598 
involved in making policy decisions on non-communicable diseases may be different and need to be 599 
examined in futures studies. Second, as acknowledged by other researchers, one of the challenges 600 
to conduct policy analysis is to obtain access to domestic policy elites (Walt et al., 2008). In our case, 601 
we were unable to include some of the higher-level actors involved in making decisions on TB 602 
policies, such as officials from NHFPC or MOF. Therefore, their views on research evidence and their 603 
roles in the TB policy process are not comprehensively examined. Third, since our study is a case 604 
study of a national HCP training program, the topic guide used in the IDIs and FGDs was designed 605 
with an emphasis on the specific program. However, based on the definition of the priori thematic 606 
saturation (Saunders et al., 2018), we believe we achieved saturation since the four constructs of the 607 
RAPID framework were adequately represented by our data. Finally, although, in this study, we 608 
investigated factors influencing research uptake by health policymakers in China, unfortunately, we 609 
were not yet updated whether the HCP training program was sustained or scaled-up. To broaden the 610 
scope of our study, a network or stakeholder analysis could be conducted in future to systematically 611 
examine all the key players involved in the TB policy process in China.  612 
 613 
CONCLUSION 614 
This case study of policy actors’ perception on using evaluation evidence to make resource allocation 615 
decisions on a national MDR-TB HCP training program in China highlighted areas that could be 616 
targeted to improve research use in the health policymaking process in the Chinese context.  The 617 
usefulness of research is determined by its context – whether it addresses a national priority that is 618 
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shaped and set by not only local policymakers but also international donors – and its scientific quality. 619 
For researchers, apart from improving the relevance and robustness of research studies, it is 620 
important to assess the policy context and frame the research scope to align with government 621 
priorities. Furthermore, we highlighted the dual roles of two agencies in the TB policy process in 622 
China as they are both evidence providers and actors who have the power to influence policy 623 
decisions through their technical expertise. Without the immediate availability of knowledge 624 
brokers, making alliances with existing key actors is an effective way to improve communication of 625 
research findings into the policy process.  626 
 627 
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